US 12263149
Levodopa dosing regimen
granted A61KA61K31/198A61K9/4825
Quick answer
US patent 12263149 (Levodopa dosing regimen) held by AMNEAL PHARMACEUTICALS LLC expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AMNEAL PHARMACEUTICALS LLC
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/198, A61K9/4825, A61K9/5005, A61K9/5026